Corpus Intelligence IC Memo — MID COAST HOSPITAL 2026-04-26 09:03 UTC
IC Memo — MID COAST HOSPITAL
Investment Committee Memorandum | ME | 93 beds | Grade C | EBITDA uplift $15.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MID COAST HOSPITAL

CCN 200021 | CUMBERLAND, ME | 93 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MID COAST HOSPITAL is a 93-bed suburban community hospital in CUMBERLAND, ME with $213.6M in net patient revenue and a -14.0% operating margin. The hospital serves a payer mix of 25.4% Medicare, 8.1% Medicaid, and 66.5% commercial.

Thesis: Turnaround. Our ML models identify $15.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.0% to -6.7% (+736bps).

Net Revenue HCRIS$213.6M
Current EBITDA COMPUTED$-30.0M
Operating Margin COMPUTED-14.0%
Occupancy HCRIS75.3%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS39.9%
Distress Probability ML42.7%

2. Market Context & Competitive Position

38
ME Hospitals
-8.3%
State Median Margin
13
Comparable Hospitals

ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -14.0% places it below the state median. Among 13 size-comparable peers (46-186 beds), the median margin is -11.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-186), prioritizing same-state peers. 13 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MID COAST HOSPITAL (Target)ME93$213.6M-14.0%
MAINEGENERAL MEDICAL CENTERME186$559.8M-17.8%
SOUTHERN MAINE HEALTH CAREME140$352.3M-9.9%
MERCY HOSPITALME77$240.0M-11.6%
YORK HOSPITALME54$197.1M-3.6%
ST. MARYS REGIONAL MEDICAL CENME140$196.3M-32.8%
ST JOSEPH HOSPITALME99$176.8M-9.2%
PENOBSCOT BAY MEDICAL CENTERME81$171.6M-21.7%
SPRING HARBOR HOSPITALME96$77.6M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.5M+210bp18mo
Cost to Collect4.5%2.5%$4.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.6M+122bp9mo
Clean Claim Rate88.0%96.0%$137K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.5M
Cost to Collect
$4.3M
Denial Rate Reduction
$4.2M
A/R Days Reduction
$2.6M
Clean Claim Rate
$137K
Total EBITDA Uplift$15.7M
Current EBITDA$-30.0M
+ RCM Uplift+$15.7M
Pro Forma EBITDA$-14.2M
Current Margin-14.0%
Pro Forma Margin-6.7%
WC Released (1x)$8.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-46.1M$-40.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-46.1M$-59.4M0.00x-100.0%
Bull Case9.0x11.0x$-41.5M$-22.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-41.5M$-36.8M0.00x-100.0%
Bear Case11.0x10.0x$-50.7M$-104.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-50.7M$-131.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 13 hospitals with 46-186 beds
  • Same-state prioritization (n=14)
  • Comp margins: P25=-19.7% / P50=-11.3% / P75=-6.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.